作者: Raquel Santos Faria , Hugo Delleon Silva , Francyelli Mello-Andrade , Wanessa Carvalho Pires , Flávia de Castro Pereira
DOI: 10.1007/S12011-020-02098-8
关键词:
摘要: Ruthenium(II)/benzonitrile complexes have demonstrated promising anticancer properties. Considering that there are no specific therapies for treating sarcoma, we decided to evaluate the cytotoxic, genotoxic, and lethal effects of cis-[RuCl(BzCN)(phen)(dppb)]PF6 (BzCN = benzonitrile; phen 1,10-phenanthroline; dppb 1,4-bis-(diphenylphosphino)butane), as well mechanism cell death induction occurs against murine sarcoma-180 tumor. Thus, MTT assay was applied assess ruthenium cytotoxicity, showing compound is a more potent inhibitor tumor viability than normal cells (lymphocytes). The comet indicated low genotoxic cells. also showed moderate lethality in Artemia salina. complex induced cycle arrest G0/G1 phase In addition, caused S180 die by apoptosis an increase Annexin-V-positive morphological changes typical apoptotic Additionally, increased gene expression Bax, Casp3, Tp53 By using western blot, observed protein level TNF-R2, p21. conclusion, active selective cells, leading at through caspases-mediated Tp53/p21-mediated pathway.